| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Pete Buttigieg says Trump's ATC attack is a distraction from his "bad deal" on health insurance and failure on "...
Centene Corporation (the Company) will appear at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at 10...
Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to Decemb...
Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk as...
Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting a...
JP Morgan analyst John Stansel maintains Centene (NYSE:CNC) with a Neutral and raises the price target from $30 to $38.
Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Equal-Weight and raises the price target from $35 to $44.